• Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting

    Источник: Nasdaq GlobeNewswire / 08 апр 2024 07:30:00   America/Chicago

    N/A
Опубликовать